Price (delayed)
$4.35
Market cap
$47.1M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.01
Enterprise value
-$78.01M
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases. The company is advancing its clinical-stage pipeline of
There are no recent dividends present for AVTX.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.